Contract Notice Detail

Summary Information


Base Total Price:	36,000.000000 Euro
Request Reference:	10C0317824
Request Name:	Aquisição de VANCOMICINA, IV, 500MG, PO SOL INJ, ao abrigo do CPA 2023/492, para a ULSASI, para o ano 2024
Phase:	Tendering Phase
State:	Awarded
Description:	Aquisição de VANCOMICINA, IV, 500MG, PO SOL INJ, ao abrigo do CPA 2023/492, para a ULSASI, para o ano 2024
Procedure Type:	VortalGOV - Acquisition under a Framework Agreement (via Direct Award)

Lot Name		Lot Base Price	Expected Duration
V53 - VANCOMICINA [500MG; IV; F/AMP]		-	265 (Days)

Object of the Contract

Type of Contract:

Supplies Acquisition

Main Object CPV Main Category:

Ic19 Amadora 2700 Venteira Amadora Lisboa PORTUGAL

CPV Main Vocabulary

33600000-6 - Pharmaceutical products

CPV Supplementary Vocabulary

Additional Classifications List

Scheduling

Request online publishing date:	4/10/2024 8:52 AM (UTC +1 hour)
National official publishing date and time (DR):	7/26/2023 8:48 AM (UTC +1 hour)
Due datetime for receiving replies:	4/12/2024 5:00 PM (UTC +1 hour)

Financial Settings

Define Warranties?

Contract Documents

Document Name	Description	Doc Classification
Anexo II.xlsx	Anexo II.xlsx	Additional Information	Download
Convite_10C0317824.pdf	Convite_10C0317824.pdf	Instruction to tenderers	Download

Object of contract

This contract is subject to renewal?	No
The procurement is related to a project and/or programme financed by European Union funds?	No

Legal, economic, financial and technical information

The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?

Questionnaire

Vision

Título do Lote

V53 - VANCOMICINA [500MG; IV; F/AMP]

Preço Base / Valor Estimado

36 000,00

1.1

Bill of Quantities

Esta lista de preços tem requisitos adicionais. Certifique-se de que tudo está completo em cada linha de artigo.

CódigoDescrição QtUnidade

V53

VANCOMICINA [500MG; IV; F/AMP]

12 000,000000

Comentários

502266791 | Hikma Farmacêutica, S.A. | CPA:2023492/62/0079 | NºAIM:5569900;

Totais(Os valores mostrados não incluem IVA)

Evaluation